Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

被引:0
|
作者
Morguetti, Maria Julia [1 ]
Neves, Precil Diego Miranda de Menezes [2 ]
Korkes, Ilana [1 ]
Padilha, Wallace Stwart Carvalho [3 ]
Jorge, Lecticia Barbosa [4 ]
Watanabe, Andreia [5 ]
Watanabe, Elieser Hitoshi [2 ]
Malheiros, Denise Maria Avancini Costa [6 ]
Noronha, Irene de Lourdes [4 ]
Dib, Sergio Atala [1 ]
Onuchic, Luiz Fernando [7 ]
Moises, Regina S. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Endocrinol, Escola Paulista Med, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Divisoes Nefrol & Med Mol, Sao Paulo, SP, Brazil
[3] Univ Fed Sao Paulo, Escola Paulista Med, Div Nefrol, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Fac Med, Div Nefrol, Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Fac Med, Div Nefrol Pediat & Med Mol, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, SP, Brazil
[7] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, SP, Brazil
来源
关键词
ACQUIRED PARTIAL LIPODYSTROPHY; PHENOTYPIC DIVERSITY; LAMIN A/C; LMNA; GLOMERULOSCLEROSIS; MUTATION; DISEASE;
D O I
10.20945/2359-4292-2023-0204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipodystrophies are characterized by complete or selective loss of adipose tissue and can be acquired or inherited. Familial partial lipodystrophy (FPLD) is a hereditary lipodystrophy commonly caused by mutations in the LMNA gene. Herein, we report two cases of FPLD associated with podocytopathies. Patient 1 was diagnosed with FPLD associated with the heterozygous p.Arg482Trp variant in LMNA and had normal glucose tolerance and hyperinsulinemia. During follow-up, she developed nephroticrange proteinuria. Renal biopsy was consistent with minimal change disease. Patient 2 was diagnosed with FPLD associated with a de novo heterozygous p.Arg349Trp variant in LMNA . Microalbuminuria progressed to macroalbuminuria within 6 years and to nephrotic range proteinuria in the last year. He remained without diabetes and with hyperinsulinemia. Renal biopsy revealed focal segmental glomerulosclerosis not otherwise specified. This report provides further evidence of variable features of lipodystrophy associated with LMNA variants and the importance of long-term follow-up with evaluation of kidney dysfunction.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
    Vasandani, Chandna
    Li, Xilong
    Sekizkardes, Hilal
    Brown, Rebecca J.
    Garg, Abhimanyu
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (12)
  • [2] Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants
    Sekizkardes, Hilal
    Cochran, Elaine
    Malandrino, Noemi
    Garg, Abhimanyu
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08): : 3068 - 3076
  • [3] Myopathy in patients with familial partial lipodystrophy due to LMNA mutations
    Spuler, S
    Kalbhenn, T
    Schmidt, HJ
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 591 - 591
  • [4] A case of familial partial lipodystrophy due to a rare homozygous LMNA mutation
    De Buitleir, Ciara
    Newman, Christine
    Griffin, Tomas
    O'Shea, Paula
    O'Brien, Timothy
    Liew, Aaron
    Dinneen, Sean
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S180 - S180
  • [5] ADIPOCYTE DYSFUNCTION IN AN IPSC MODEL OF FAMILIAL PARTIAL LIPODYSTROPHY DUE TO MUTATIONS IN LMNA
    Alvarez, Aluet Borrego
    Liu, Katie
    Gobble, McKinlee
    Grupe, Michael
    Buchser, William
    Baldridge, Dustin
    Stone, Stephen
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 154 - 155
  • [6] Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
    Owen, KR
    Donohoe, M
    Ellard, S
    Hattersley, AT
    DIABETIC MEDICINE, 2003, 20 (10) : 823 - 827
  • [7] Cardiac laminopathy in familial partial lipodystrophy type 2 secondary to variants in the LMNA gene
    Moreno Tirado, Antonio
    Rodriguez Ortega, Pilar
    Calle Isorna, Jose Maria
    MEDICINA CLINICA, 2024, 163 (12): : 634 - 635
  • [8] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    D. B. Savage
    I. McFarlane
    I. Barroso
    M. A. Soos
    A. Powlson
    E. L. Thomas
    J. D. Bell
    I. Scobie
    P. E. Belchetz
    W. F. Kelly
    D. J. Halsall
    A. J. Schafer
    S. O’Rahilly
    Diabetologia, 2004, 47 : 753 - 756
  • [9] Partial lipodystrophy associated with juvenile dermatomyositis: Report of two cases
    Quecedo, E
    Febrer, I
    Serrano, G
    MartinezAparicio, A
    Aliaga, A
    PEDIATRIC DERMATOLOGY, 1996, 13 (06) : 477 - 482
  • [10] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    Savage, DB
    Soos, MA
    Powlson, A
    O'Rahilly, S
    McFarlane, I
    Halsall, DJ
    Barroso, I
    Thomas, EL
    Bell, JD
    Scobie, I
    Belchetz, PE
    Kelly, WF
    Schafer, AJ
    DIABETOLOGIA, 2004, 47 (04) : 753 - 756